A rheumatoid arthritis medication helped 54% of people achieve depression remission when standard antidepressants failed them.
Researchers tested tocilizumab, an arthritis drug that blocks inflammatory protein interleukin-6, in 30 people whose depression hadn't improved with traditional antidepressants. After four weeks, 54% of people taking the drug achieved remission compared to 31% on placebo. The drug also reduced fatigue and anxiety while improving quality of life. This matters because roughly one-third of people with depression don't respond to standard medications that target brain chemicals.
The study was small, but the results are striking enough to warrant attention. About one in three people with depression have elevated inflammatory markers in their blood, suggesting their immune system is contributing to symptoms. Instead of trying another serotonin-targeting antidepressant, this approach treats depression like an inflammatory condition. The number needed to treat was 5, meaning five people need treatment for one additional person to benefit — slightly better than common antidepressants.
This research points toward personalized depression treatment based on your biology rather than trial-and-error prescribing. If you have treatment-resistant depression and blood tests show inflammation, an anti-inflammatory approach might work when brain-focused medications don't. The next step is a larger trial to determine if doctors should start prescribing immunotherapy for depression more broadly.
What You Can Actually Do Today
- If your depression isn't responding to treatment, ask your doctor about testing inflammatory markers like interleukin-6 in your blood
- Keep a symptom diary tracking depression, fatigue, and physical symptoms to identify patterns that might suggest inflammation
- Research clinical trials for treatment-resistant depression in your area, as immunotherapy studies may be recruiting participants
This treatment is experimental and not yet available outside clinical trials. Discuss all depression treatments with your healthcare provider.
